RecruitingPhase 3NCT07177352
Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
Sponsor: Hoffmann-La Roche
Plymouth Meeting, PA · +67 more sites
Clinical trials in Plymouth Meeting, PA
6 recruiting studies have a site in or near Plymouth Meeting, PA, Pennsylvania.
Top conditions here
All conditions
- Alzheimer's Disease
- Asthma
- Breast Cancer
- COPD
- Crohn's Disease
- Depression
- Type 1 Diabetes
- Type 2 Diabetes
- Heart Failure
- Hypertension
- Leukemia
- Lung Cancer
- Lupus
- Migraine
- Multiple Sclerosis
- Obesity
- Parkinson's Disease
- Prostate Cancer
- Psoriasis
- Rheumatoid Arthritis
- Schizophrenia
- Sickle Cell Disease
- Ulcerative Colitis
- Colorectal Cancer
Showing 6 of 6 studies
RecruitingPhase 3NCT06976203
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)
Sponsor: Bristol-Myers Squibb
Plymouth Meeting, PA · +30 more sites
RecruitingPhase 2NCT07033494
A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)
Sponsor: Merck Sharp & Dohme LLC
Plymouth Meeting, PA · +35 more sites
RecruitingPhase 4NCT06857942
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
Sponsor: Eli Lilly and Company
Plymouth Meeting, PA · +38 more sites
RecruitingPhase not listedNCT07076303
A Prospective Study on the Efficacy of Direct Selective Laser Trabeculoplasty (DSLT) in Achieving >20% Intraocular Pressure (IOP) Reduction Without Medications at 6 Months in Naive, Untreated Glaucoma Patients
Sponsor: Brian Shafer
Plymouth Meeting, PA
Not yet recruitingPhase 3NCT07881432
A Study of EloraTZP in Adult Participants With Obesity Without Type 2 Diabetes
Sponsor: Eli Lilly and Company
Philadelphia, PA · Plymouth Meeting, PA · +53 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.